Short answer · Medically reviewed summary · Last updated: 2026-05-08
Congenital Fiber Type Disproportion (CFTD) is a rare congenital myopathy primarily identified by the predominance and small size of type 1 muscle fibers. While it is most commonly referred to by this descriptive term, it is sometimes historically or clinically categorized under broader umbrellas such as "Congenital Myopathy with Fiber Type Disproportion" or specific genetic variants related to the ACTA1, SELENON, or TPM3 genes. What are the common synonyms for Congenital Fiber Type Disproportion? In medical literature, Congenital Fiber Type Disproportion is occasionally referred to by names that reflect its pathological findings rather than a single genetic cause.
Congenital Fiber Type Disproportion synonyms
Other names for Congenital Fiber Type Disproportion: synonyms, acronyms and related terms used by doctors and patients.
Congenital Fiber Type Disproportion (CFTD) is a rare congenital myopathy primarily identified by the predominance and small size of type 1 muscle fibers. While it is most commonly referred to by this descriptive term, it is sometimes historically or clinically categorized under broader umbrellas such as "Congenital Myopathy with Fiber Type Disproportion" or specific genetic variants related to the ACTA1, SELENON, or TPM3 genes.
What are the common synonyms for Congenital Fiber Type Disproportion?
In medical literature, Congenital Fiber Type Disproportion is occasionally referred to by names that reflect its pathological findings rather than a single genetic cause. Because the condition was historically defined by muscle biopsy results before the era of widespread genetic testing, you may encounter the following terms in older medical records or international literature:
- CFTD (the standard clinical abbreviation)
- Congenital myopathy with fiber type disproportion
- Fiber type disproportion myopathy
- Type 1 fiber predominance and hypotrophy
Why does this condition have multiple names?
The naming of Congenital Fiber Type Disproportion has evolved significantly alongside advancements in genomic medicine. Historically, the diagnosis was made strictly via muscle biopsy, which showed that type 1 muscle fibers were significantly smaller than type 2 fibers. As researchers discovered that many cases of Congenital Fiber Type Disproportion are actually caused by mutations in specific genes (such as ACTA1 or SELENON), some clinicians now prefer to use the gene-specific diagnosis if known. This shift explains why older medical texts might use a broader term, while modern specialists prioritize the underlying genetic etiology.
What is the official classification for this condition?
Medical professionals currently prefer the term Congenital Fiber Type Disproportion as it remains the most accurate clinical descriptor for the muscle pathology observed. In major international databases, the condition is classified as follows:
- Orphanet: Listed under ORPHA:163688.
- OMIM (Online Mendelian Inheritance in Man): Referenced under #255310.
- ICD-10/11: Often coded under broader categories for congenital myopathies, such as G71.2.
Next steps
- Discuss your specific genetic report with a neuromuscular specialist to see if your Congenital Fiber Type Disproportion has an identified gene mutation.
- Connect with the 17 community members on DiseaseMaps.org to share experiences regarding diagnosis and management.
- Request a referral to a genetic counselor to understand the inheritance pattern relevant to your family.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Congenital Fiber Type Disproportion
- Orphanet: Congenital fiber type disproportion (ORPHA:163688)
- OMIM: Congenital fiber-type disproportion (Entry #255310)
- PubMed: Clinical and genetic spectrum of Congenital Fiber Type Disproportion
